Change Language

Select Language

Europe Baby Food and Infant Formula Market to Reach US$ 12.5 Billion by 2027, Supported by Rising Female Workforce Participation

Published on Oct 28, 2022

According to the latest report by IMARC Group, titled “Europe Baby Food and Infant Formula Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the Europe baby food and infant formula market reached a size of US$ 8.7 Billion in 2021. Baby food and infant formula refer to edible products marketed and designed to feed babies and infants. It includes milk formula and prepared and dried food products manufactured using mashed fruits, vegetables, and cereals. Baby food and infant formula contain carbohydrates, vitamins, minerals, iron, purified whey and casein, and vegetable oil as the main source of fat. They are designed as a complete substitute for human milk to meet the overall nutritional needs of toddlers. Baby food and infant formula promotes health, enhance cognitive development, prevent allergies, and increase gastrointestinal health and immunity. They also ensure infants and young children have an adequate amount of safe, bioavailable nutrients with a proper physiological effect.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Europe Baby Food and Infant Formula Market Trends:

The rising female workforce participation is one of the key factors driving the market growth in the region. Baby food and infant formula is widely used by working parents, especially mothers who resume their job shortly after giving birth, to provide a convenient, healthy, and nutritious diet to the child. In addition, the increasing parental concerns regarding the health and nutritional requirements of their children are acting as another factor contributing to the market growth. Furthermore, widespread product utilization as a special diet for infants with stomach sensitivity and metabolic illnesses is providing a considerable boost to market growth. Additionally, leading players are continuously investing in research and development (R&D) activities to launch innovative product variants with improved taste, such as lactose-free, organic, natural, and soy-based formulas. Such products are formulated without pesticides, artificial flavors, colors, preservatives, and sweeteners, which, in turn, is creating a positive outlook for the market. Apart from this, manufacturers are adopting innovative, green, and recyclable packaging solutions, such as stand-up pouches and flexible barrier bags, to address the rising environmental concerns, which is providing an impetus to market growth. Other factors, including rising expenditure capacities of consumers, easy product availability across various e-commerce platforms, and improved distribution channels, are anticipated to drive the market toward growth in Europe. On account of the aforementioned factors, the market value is expected to reach US$ 12.5 Billion by 2027, exhibiting a CAGR of 6% during 2022-2027.

Market Summary:

  • On the basis of the type, the market has been divided into milk formula, dried baby food, prepared baby food, and others.
  • Based on the distribution channel, the market has been classified into supermarkets and hypermarkets, pharmacies, convenience stores, and others.
  • On a regional basis, the market has been categorized into Germany, France, the United Kingdom, Italy, Spain, and others.
  • The competitive landscape of the industry has also been examined along with the profiles of some key players.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

4